Login / Signup
Helena Dračínská
ORCID
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 2
Top Topics
Ms Ms
Poor Prognosis
Induced Pluripotent Stem Cells
Highly Efficient
Top Venues
Acta pharmaceutica (Zagreb, Croatia)
International journal of molecular sciences
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Radek Indra
,
Sandra Jelínková
,
Katarína Kollárová
,
Petra Zahumenská
,
Josef Dvořák
,
Šárka Dušková
,
Helena Dračínská
The tyrosine kinase inhibitor lenvatinib is oxidized by rat cytochromes P450 and affects their expression in rat liver.
Acta pharmaceutica (Zagreb, Croatia)
74 (3) (2024)
Helena Dračínská
,
Radek Indra
,
Sandra Jelínková
,
Věra Černá
,
Volker Manfred Arlt
,
Marie Stiborová
Benzo[a]pyrene-Induced Genotoxicity in Rats Is Affected by Co-Exposure to Sudan I by Altering the Expression of Biotransformation Enzymes.
International journal of molecular sciences
22 (15) (2021)